Tag: IGNG

CannabisNewsBreaks – Grapefruit Boulevard Investments, Inc. (IGNG) Files Amendment No. 1 to Registration Statement

Grapefruit Boulevard Investments (“GBI”), a licensed and fully compliant California based cannabis distribution and manufacturing company and a wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG) (collectively “Grapefruit”), this morning announced that it has filed Amendment No. 1 to its Registration Statement on Form S-1 that was originally filed on July 28, 2019 regarding conversions of convertible notes issued to the company’s institutional investor Auctus Fund, LLC. “We are very pleased to file the Amendment which puts us back on track to complete the Auctus transaction. Pursuant to the terms of our Agreements with Auctus, immediately upon effectiveness of the Registration Statement, which we believe should occur in late February of 2020 we will receive a new Convertible Note Tranche of $750,000.00 from Auctus and 90 days later a final Convertible Note Tranche of $1,000,000.00. These funds are key to our revenue growth in 2020. In addition, as our common stock price increases in the future, we will be able to call warrants to bring in additional working capital. We are currently focused on ramping up revenues to justify an increased stock price which will afford us the opportunity to call the Warrants. We are also in the process of evaluating other capital raising possibilities. We feel we have regained our momentum which was temporarily slowed by the delay in the Grapefruit Boulevard Investment audit and look forward to 2020 and the myriad possibilities the future holds for Grapefruit,” Grapefruit CEO Bradley J. Yourist stated in the news release.

To view the full press release, visit http://cnw.fm/DEBv5

About Grapefruit Boulevard Investments Inc.

Grapefruit is a wholly-owned subsidiary of Imaging3, Inc. Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 14 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis company. For more information, visit the company’s website at www.Grapefruitblvd.com.

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://cnw.fm/IGNG

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit Boulevard Investments, Inc. (IGNG) Enters Reseller LOI with Pacific Banking Corp.

Grapefruit Boulevard Investments (“GBI”), a licensed and fully compliant California based cannabis distribution and manufacturing company and a wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG) (collectively “Grapefruit”), today announced its entry into a non-binding reseller letter of intent (“LOI”) with Seattle, Washington based Pacific Banking Corp. (“PBC”). Under the agreement, Grapefruit will market PBC’s unique, innovative and compliant banking services to properly licensed and compliant cannabis and hemp companies in Southern California which meet certain PBC qualitative criteria and metrics. “Our relationship with Mr. Costello grew to the point that on or about September 11, 2019, we appointed him to be the first member of our Strategic Advisory Board. Now that we are comfortable using PBC’s banking service, we will team up with PBC to offer PBC’s banking solutions in Southern California to properly licensed, compliant hemp and cannabis companies which pass PBC’s client screening regimen,” Grapefruit CEO Bradley J. Yourist said in the news release. “We will only accept companies that demonstrate bulletproof compliance and ethical corporate governance. Over the next thirty days, Grapefruit and PBC will negotiate a definitive agreement. Once the definitive agreement is finalized and executed Grapefruit will work with PBC to commence marketing PBC’s specialized cannabis and hemp banking services in Southern California.”

To view the full press release, visit http://cnw.fm/5ep4E

About Grapefruit Boulevard Investments Inc.

Grapefruit is a wholly-owned subsidiary of Imaging3, Inc. Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 14 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis Company. To obtain further information on Grapefruit and its operations, please visit its website at www.Grapefruitblvd.com. To learn more about Grapefruit’s Sugar Stoned branded line of cannabis and CBD infused edibles, please visit www.SugarStoned.com.

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://cnw.fm/IGNG

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Congressional Committee to Debate Two Marijuana Legalization Bills This Week

On Friday, a memo briefing to the effect that when the legislative session starts this week, a Congressional committee would be debating two legislations seeking to legalize marijuana at the federal level as well as other marijuana research legislations.

On Wednesday, the House Energy and Commerce subcommittee will hold a hearing on several reform proposals, with testimonies from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), and National Institute on Drug Abuse (NIDA) witnesses.

This comes two months after the House Judiciary Committee approved the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, which was sponsored by Chairman Jerrold Nadler (D-NY). The MORE Act is one of the bills being taken up by the Energy and Commerce Subcommittee on Health on January 15.

The obtained memo starts by detailing the content of the marijuana policy in the U.S., such as the restrictions imposed by the Controlled Substances Act (CSA) on marijuana research, legalization of industrial hemp, petitions submitted in the past seeking for marijuana rescheduling, and public health issues.

Some of the witnesses for the scheduled hearing include Matthew Strait, who is the DEA Senior Policy Advisor, FDA Deputy Director for Regulatory Programs Douglas Throckmorton, and the Director of NIDA Nora Volkov.

Discussed below are some of the bills which will be debated next week.

Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act

The MORE Act aims to remove marijuana from the list of controlled substances Act. It is also seeking for expungement of the records of past marijuana convictions, as well as imposing a five percent tax on marijuana sales. Revenues from the sales would be reinvested in communities most affected by the war against drugs.

The MORE Act would also create a way for resentencing people jailed for marijuana felonies. It would also ensure that immigrants are not denied citizenship because of marijuana. The bill has provisions to ensure that weed users are not blocked from receiving public benefits and security clearance by federal agencies.

Marijuana Freedom and Opportunity Act

The legislation was sponsored by Rep. Hakeem Jeffries (D-NY). The bill’s provisions are to deschedule marijuana at the federal level, create a fund that supports minorities and marijuana businesses owned by women as well as providing grants to marijuana ex-convicts.

Medical Marijuana Research Act of 2019

It was sponsored by Rep. Matt Gaetz (R-FL). The bill seeks approval of more manufacturers of research-grade cannabis, protects institutions researching weed, and gives permission to the Department of Veteran Affairs in the U.S. to present patients with the option of treating their conditions using marijuana.

Medical Marijuana Research Act of 2019

A bipartisan group of House members led by Rep. Earl Blumenauer (D-OR) introduced the legislation. It has provisions simplifying the process of registration for researchers interested in studying marijuana. It also permits private manufacturers to supply researchers with research-grade marijuana.

Legitimate Use of Medicinal Marijuana Act

It was introduced by Rep. Morgan Griffith (R-VA). It aims at moving marijuana from Schedule I to Schedule II. It also aims at clarifying that transportation, use, possession, production, and distribution of medical marijuana cannot be prohibited by the federal government.

Veterans Medical Marijuana Safe Harbor Act

It was sponsored by Rep. Barbara Lee (D-CA). Its aim is to allow military veterans to use, possess, or transport medical pot under federal law. Veteran Affairs doctors would also be permitted to recommend medical marijuana to their patients.

It would be eye-opening to hear what industry actors like Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) think of the odds that those bills will make it through both legislative chambers and become law.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Reports Positive Time-Release Efficacy Results from Initial THC Patchless Patch Laboratory Testing

Grapefruit Boulevard Investments, a Los Angeles based California corporation and wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG), (collectively “Grapefruit”), this morning reported successful results from the initial round of laboratory testing of the time release efficacy of its patented THC Patchless Patch(TM) topical cream. The results showed that the product can deliver a consistent, reliable pre-defined dose of THC via a user’s skin throughout an estimated ten-hour time period. “The results of these tests of Grapefruit’s patented THC Cannabinoid time-release Patchless Patch have demonstrated its efficacy. Grapefruit believes that the consistent and sustained delivery of THC Cannabinoids over a defined period has the potential to change the manner in which chronic long-term pain and other disorders are managed. It also has the potential to provide an alternative to the use of highly addictive opioids for the treatment of chronic pain. Our hope is that this potentially game-changing technology will allow people who suffer from chronic pain and other disorders to lead more active and productive lives. Furthermore, our THC Patchless Patch has obvious applications in the recreational cannabis context for use at events such as concerts and movies as well as transcontinental flights. We are targeting the end of the Second Quarter of 2020 to bring the product to market. We will keep our shareholders and the public apprised of further developments with the THC Patchless Patch as they occur,” Grapefruit CEO Bradley J. Yourist stated in the news release.

To view the full press release, visit http://cnw.fm/3BIrB

About Grapefruit Boulevard Investments Inc.

Grapefruit is a wholly-owned subsidiary of Imaging3, Inc. Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 10 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis Company. To obtain further information on Grapefruit and its operations, please visit its website at www.Grapefruitblvd.com. To learn more about Grapefruit’s Sugar Stoned branded line of cannabis and CBD infused edibles, please visit www.SugarStoned.com.

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://cnw.fm/IGNG

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Illinois Residents Buy Recreational Marijuana Worth $3.2 Million on the First Day of Legal Sales

On Thursday, it was announced that the first day of legal adult-use marijuana sales in Illinois attracted more than 77,000 transactions, which generated approximately $3.2 million in sales. One of the transactions was made by the second-most powerful official in the state, Lieutenant Governor, Juliana Straton, who bought edible gummies. Stratton said that she was there to celebrate the big day in Illinois.

According to Toi Hutchinson, the sale of legal recreational marijuana took effect on New Year’s Day, and the state-licensed dispensaries made 77,128 transactions. Hutchinson is the senior advisor to Governor J.B. Pritzker on marijuana control.

The retail outlets reported long lines of customers during the first day of legal sales, and they expect the lines to persist through the weekend.

Speaking to a reporter on Thursday in Chicago, Hutchinson said that the long lines show that there is a massive opportunity for the cannabis industry to grow.

When compared to other states such as the bordering Michigan, which generated $3.1 million in its first two weeks of legal adult-use sales after the launch on December 1,  it shows that Illinois has a potential for growth since it exceeded that amount within just the first day of sales.

Colorado was the first state in the U.S. to legalize adult-use cannabis. The state launched the sale of marijuana on January 1, 2014 and generated over $1million in sales.

Hutchinson further said that Thursday was the deadline for those who wished to apply for business licenses under the social equity provisions. The day also marked phase two of the Illinois legalization law.

Phase two of the legalization law is meant to help minority applicants who were severely affected by the fight against drugs. The social equity provisions require qualified applicants to pay lower licensing fees. It also provides them with business loans and any other technical assistance.

The legalization laws also stipulate that some of the marijuana revenues would be used for neighborhood development grants. It also had a provision for expungement of low-level marijuana convictions.

On Tuesday last week, Pritzker granted more than 11,000 pardons to people with low-level marijuana convictions.

On the day of legal sales launch, Wednesday, people began streaming in at the dispensaries as early as 6 a.m. Medical marijuana is already legal in Illinois, and now, Illinois is the 11th state to legalize the consumption and sale of adult-use cannabis.

In Illinois, people who are 21 years and above can possess up to 1.06 ounces of marijuana buds and up to 0.17 ounces of marijuana concentrate.

The executive director of the Cannabis Business Association of Illinois, which is based in Springfield, Pamela Althoff, said that most of her Wednesday morning was spent in Chicago and Northwestern suburbs, where customers had to wait for about three hours to be served as the day progressed. She also noted that people were courteous and civil, and the police were present at most dispensaries to control traffic.

Althoff advised consumers not to use marijuana in public and also noted that, like any other new product, marijuana products might be a little costly. Althoff further that they hope that the prices will go down as the market matures.

About 36 licensed dispensaries are selling recreational marijuana, and by May 2020, the state officials said that they would have issued 75 more permits. State officials further estimate that by the end of 2020, Illinois could generate $250million from marijuana sales.

Experts believe that marijuana companies like Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) and MCTC Holdings Inc. (OTC: MCTC) are happy for their counterparts operating in Illinois since the success of the industry there is good for all sector players.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – A Primer on Medical Marijuana Products and Dosage Tips

There is a variety of medical marijuana products used to treat various diseases and conditions in the world today. People can use these products through various modes of delivery such as:

  • Ingestion of liquids such as oils, tinctures, and drinks infused with medical marijuana;
  • Intake of solids such as capsules or tablets, edibles, and regular foods mixed with medical marijuana oil or powder;
  • Topical administration directly on the skin. The products include creams, salves, balms, ointments, and transdermal patches;
  • Suppositories such as tablets or capsules;
  • Inhalation, which is achieved by smoking dried buds, vaping, or dabbing; and
  • Insufflation through the use of nasal sprays.

No method of delivery can be termed as perfect because each of the methods has its pros and cons. For some, the relief may be instant, while others take longer before they can feel the effects of weed, while others react with a specific area of the body.

The ability to prescribe the correct dosage of medical marijuana products to treat a medical condition is a vital element when choosing the mode of delivery. Doctors should also consider the patient’s lifestyle as well as their ability to consume drugs reliably and effectively. For example, a strong THC dosage may be effective in treating illness, but it may end up impairing drivers or people operating heavy machinery. Therefore, doctors should advise patients to take small doses at intervals during the day, which will ensure that they get all the benefits required to treat the condition.

Another factor affecting the delivery of medical marijuana is the ‘first pass effect.’ The first-pass effect is the process where enzymes found in the liver breakdown CBD and THC before they are absorbed in the brain or other body organs. This means the dosage getting to the intended location is a smaller proportion than what was ingested.

Patients should note that CBD and THC are not water soluble and that the cannabinoids mix well with fats and oils. For this reason, it is best to consume them along with a fatty meal. It is also important to note that cannabinoids are sensitive to light and oxygen; that is why weed is stored in dark bottles or shelves.

It is recommended for patients to start with low doses and see how it affects the body before increasing the dosage; this method is referred to as dose titration. It is suitable for taking THC medication.

Patients can also take minute doses of the medicine to get the positive benefits without experiencing the adverse side effects of a large dose. This method is referred to as microdosing. Patients can take a small dosage, such as 1/20 of the total dose. It is ideal for anxiety, depression, and insomnia.

Tablets and capsules are an accurate and precise method of dosing. They are easily portable and discreet as you can take them in public. They also have a long-lasting effect.

Due to technological advancements and innovations, in the future, patients will have the opportunity to choose products designed to suit their specific needs as well as advanced methods of delivery such as nasal sprays or transdermal patches capable of increasing or lowering dosages automatically.

Experts believe that marijuana companies such as Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) and IONIC Brands Corp. (CSE: IONC) (OTC: IONKF), are working round the clock to perfect their products and develop novel delivery systems.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Senators Pressure DEA to Provide Update on Cannabis Grower Applications

Top federal drug and health agencies are under pressure from a group of senators to provide an update about the long overdue increase in the number of authorized marijuana manufacturers for study purposes.

Led by Senator Elizabeth Warren (D-MA), the lawmakers wrote a letter emphasizing the importance of expanding the supply of research-grade marijuana as more states move to legalize marijuana either for recreational or medical consumption. The letter was addressed to the Drug Enforcement Administration (DEA), Office of National Drug Control Policy, and the Department of Health and Human Services.

Although the DEA announced that it would approve additional marijuana growers for research-grade weed more than three years ago, it is yet to deliver on its promise since it keeps delaying the process. In August the agency said that it is in the process of approving the applications; however, due to the large number of applications, it will have to establish alternative rules before issuing new permits.

The DEA made that announcement before the deadline issued by the court previously, which required the agency to take action. The lawsuit against the DEA was filed by a researcher whose application for marijuana production for research purposes had been suspended. The court dismissed the suit in October since the agency provided an update.

However, the senators were not placated by the agency’s response, and they are seeking guidance on the process to be taken to ensure that the qualified researchers are granted licenses on time.

The letter which was sent on Wednesday last week said that the number of studies covering the therapeutic effects of cannabis is limited even though millions of U.S. citizens are legally permitted to consume medical or recreational marijuana. The letter further noted that the number of Americans seeking doctors’ advice on marijuana treatment for ailments, such as chronic pain, PTSD, or terminal illnesses is ever-growing; therefore, federal agencies should make an effort to increase the amount of credible information on marijuana health benefits and health risks.

Being classified under Schedule 1 of the Controlled Substances Act creates a barrier for researchers to conduct studies on marijuana.

The lawmakers also argued in the letter that inhibiting research opportunities and discouraging researchers who are independent and qualified from conducting studies on the benefits of marijuana is a hindrance to states looking to implement their marijuana laws.  Marijuana studies are vital to developing an understanding of marijuana, and the findings would be a gem to the doctors, patients, and lawmakers across the U.S.

The letter also poses five questions to the agencies, and they expected the response by January 10.

  1. The status and timeline of application approval by the DEA
  2. Information about the existing supply of research-grade marijuana and if the facility is cultivating more varieties.
  3. Information on whether the government would reschedule marijuana
  4. The application process guidelines.
  5. Their support for research on the therapeutic effects of marijuana

The senators also wrote that there is a need for evidence-based public policy, which is vital to securing the health of the citizens since millions of Americans can now access medical and recreational marijuana. They added that the federal government should provide the necessary leadership and tools required in developing research in cannabis.

Other senators who signed the letter include Ron Wyden (D-OR), Kristen Gillibrand (D-NY), Cory Booker (D-NJ), Ed Markey (D-MA), and Jacky Rosen (D-NV).

To what extent will such letters result in tangible results on the regulatory front? Experts cannot be certain that marijuana companies like Dama Financial and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) are still keeping count of the different letters that have been written to the federal authorities on matters of marijuana policy reform since the feds seem to be working based on their own schedule.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Announces FINRA Filing to Change Corporate Name and Stock Ticker Symbol

Grapefruit Boulevard Investments, a Los Angeles based California corporation and wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG), (collectively “Grapefruit”), this morning announced that, as of today, December 16, 2019, it has filed with the Financial Industry Regulatory Authority (“FINRA”) to change the company’s corporate name to Grapefruit USA, Inc., and stock ticker symbol to “GUSA,” “GPRE,” “GPFT” or such other symbol as FINRA and Grapefruit may agree. “Now that Grapefruit’s audit is complete and IGNG’s Super 8K has been filed, we are pleased to take this final step to formalize our transition from a development stage medical device company to a fully compliant, California licensed revenue producing cannabis company,” Grapefruit CEO Bradley J. Yourist said in the news release. “Our new corporate name reinforces our strong brand and the new ticker symbol emphasizes our departure from the Company’s past. These changes cement our new corporate identity and unite it with our strong brand. The Grapefruit team embraces this departure from the past and transition to an unlimited dynamic growth future for the Company and its shareholders.”

To view the full press release, visit http://cnw.fm/h8I9t

About GRAPEFRUIT

Grapefruit is a wholly-owned subsidiary of Imaging3, Inc. Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 10 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis Company. To obtain further information on Grapefruit and its operations, please visit its website at www.Grapefruitblvd.com. To learn more about Grapefruit’s Sugar Stoned branded line of cannabis and CBD infused edibles, please visit www.SugarStoned.com.

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://cnw.fm/IGNG

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Secures Weekly Purchase Agreement Contract; CEO Discusses Various Revenue Streams

Grapefruit Boulevard Investments, a Los Angeles based California corporation and wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG), (collectively “Grapefruit”), this morning announced that the company entered into a weekly purchase agreement on Friday, December 6, 2019. Per the agreement, IGNG will supply “fresh-frozen” cannabis flowers to a sizeable, Oakland, California-based cannabis extractor and manufacturer. Grapefruit CEO Bradley J. Yourist also commented on the company’s recent completion of its audit and “Super” 8K. “The sale of ‘fresh frozen’ cannabis flowers to multiple manufacturers is just one of the many revenue streams that Grapefruit is developing, including, but not limited to, the wholesale distribution of dried and cured cannabis flowers, cannabis trim, cannabis distillate & crude oil produced at our state of the art Coachillin extraction plant, cannabis creams and cannabis infused edibles. Furthermore, as stated in previous communications to our shareholders, Grapefruit continues to move vigorously ahead with the testing and manufacturing of our patented THC ‘patchless patch’ topical cream which is able to deliver a defined dose of THC to our customers through the skin over an extended period of time. Our ability to exploit multiple revenue streams affords us a strategic advantage over competitors because it allows us to quickly adapt to ever evolving industry trends and to serve multiple customers with differing needs across the cannabis spectrum,” Grapefruit CEO Bradley J. Yourist stated in the news release. “Finally, with respect to the completion of the Grapefruit audit and the filing of our ‘Super’ 8K, Grapefruit is now one of just two revenue producing, audited, fully reporting, multiple licensed California cannabis companies listed on the OTCQB which provides us with a solid foundation from which to expand our operations and revenues through strategic acquisitions of other cash flowing cannabis companies in the State of California, throughout the United States and globally. As a result of our efforts to date, Grapefruit is poised to deliver tremendous value to our shareholders.”

To view the full press release, visit http://cnw.fm/bY2Ue

About Grapefruit

Grapefruit is a wholly-owned subsidiary of Imaging3, Inc. Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 14 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis product Company. To obtain further information on Grapefruit and its operations, please visit its website at www.Grapefruitblvd.com. To learn more about Grapefruit’s Sugar Stoned branded line of cannabis and CBD infused edibles, please visit www.SugarStoned.com.

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://cnw.fm/IGNG

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Huge Demand Forces Michigan Recreational Weed Retailers to Impose Purchase Limits

In Michigan, recreational marijuana business is booming. On Wednesday, a recorded message from Arbors Wellness in Ann Arbor said that currently, the shop has a high number of customers, which is keeping them extra busy and they are therefore unable to answer calls. The overwhelming demand has even led to purchase limits being imposed by the retailers.

The sale of recreational marijuana in Michigan was launched on December 1 and since then, demand has been so high that businesses were forced to turn away customers at some point. On the first day of recreational sales, four shops generated an average of $221,000.

On Wednesday, Arbor Wellness owner, James Daly, said that they had a line of customers all day and that they are working through the lines professionally with a wait time of approximately 40 minutes.

Greenstone Provisions in Ann Arbor employees said that by 1 pm on Wednesday, the wait time to get served was about 2-hours. While on Tuesday, customers had to wait for 3 to 4-hours before getting served at Exclusive Brand’s dispensary in Ann Arbor.

Michigan Supply and Provisions in Morenci, located along the border with Ohio, is having a steady flow of customers; however, on Wednesday afternoon, no customers were waiting in line to be served.

On Sunday and Monday, Greenstone Provisions had to turn away hundreds of potential customers because it had run out of stock of marijuana buds. Since then, the retail outlets made a point of restocking daily.

Marijuana shops have been forced to institute a purchase cap on the amount of marijuana each individual is supposed to buy because of the massive demand. Greenstone Provisions, Michigan Supply, and Provisions in Morenci have instituted a sale limit of 7 grams of marijuana flower per person.

Arbor Wellness’ sale limit is 1/8 of an ounce of flower. They also have a purchase limit of two edibles, seven pre-rolled joints, and 15 vaping cartridges.

The only dispensary that did not institute purchasing caps is Exclusive Brands. On Wednesday, Omar Hishmesh, Exclusive Brands co-owner, said that they are not putting any sale limit since they are not going to run out of stock. He further noted that they are fully stocked and are actively re-stocking products; thus, no shortages.

According to Michigan laws, the sale limit for the flower is 2.5 ounces, which includes a maximum of 15 grams of concentrate.

In-store inventory is moving like a hotcake, which makes real-time resupplying difficult; however, business owners still insist product shortages will not happen any time soon.

Currently, there are three licensed recreational marijuana processing plants and one licensed transportation business in Michigan.

Greenstone Provisions and Michigan Supply and Provisions inventory is at the mercy of their competition since the three licensed processing facilities are owned by their competitors. The three facilities are owned by Exclusive Brands, Arbor Wellness, and Green Peak. Green Peak is the largest processing facility in Michigan, and it is planning on establishing retail locations across the state.

It would be interesting to hear what cannabis companies, such as Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG), have to say about how things are looking up for the industry in Michigan.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.